Seven Fleet Capital Management LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 17, 2026), Seven Fleet Capital Management LP reported 96 stock positions worth $605.9 million. Its top holding was CG Oncology (CGON) at 22.1% of the portfolio, followed by Tango Therapeutics (TNGX, 15.8%) and Revolution Medicines (RVMD, 7.5%). Compared with Q1 2026, it opened 23 new positions, sold out of 42, added to 43 and reduced 23. The biggest buy was CG Oncology (CGON, shares +2390%) and the biggest sale an exit from CG Oncology.
- Most Recent 13F
- Q2 2026
- Location
- MOUNTAIN VIEW, CA
- CIK
- 0002092021
- Portfolio Value
- $605.9M (Q2 2026)
- SEC Filing
- 0001013594-26-000921 ↗ filed Aug 17, 2026
Holdings Value
Holdings 96 stocks · $605.9M
| CGON CG Oncology Inc. | 22.12% | 1,886,236 | $134.0M | Add +2389.8% |
| TNGX Tango Therapeutics Inc. | 15.79% | 3,228,144 | $95.7M | Add +543.0% |
| RVMD Revolution Medicines Inc. | 7.48% | 242,029 | $45.3M | Add +199.6% |
| PHVS Pharvaris NV | 4.42% | 774,501 | $26.8M | Add +348.4% |
| LQDA Liquidia Corp. | 3.38% | 256,603 | $20.5M | Add +36.6% |
| ELVN Enliven Therapeutics Inc. | 3.06% | 365,386 | $18.5M | Add +122.8% |
| ABVX Abivax SA-ADR | 2.45% | 111,334 | $14.8M | Add +158.6% |
| AVTX Avalo Therapeutics Inc. | 2.35% | 770,765 | $14.2M | Add +260.5% |
| MIRM Mirum Pharmaceuticals Inc. | 2.13% | 110,393 | $12.9M | New |
| ASMB Assembly Biosciences Inc. | 1.96% | 433,147 | $11.9M | Add +671.5% |
| IPSC Century Therapeutics Inc. | 1.76% | 4,347,826 | $10.7M | Add +47.5% |
| CYTK Cytokinetics Inc. | 1.66% | 118,240 | $10.1M | Add +93.0% |
| TSHA Taysha Gene Therapies Inc. | 1.64% | 1,504,400 | $9.9M | Add +140.4% |
| MANE Veradermics Inc. | 1.62% | 80,000 | $9.8M | New |
| AVBP Arrivent Biopharma Inc. | 1.41% | 246,606 | $8.6M | Add +390.7% |
| TARS Tarsus Pharmaceuticals Inc. | 1.31% | 117,067 | $7.9M | Add +491.3% |
| XNCR Xencor Inc. | 1.29% | 368,305 | $7.8M | Add +360.4% |
| ROIV Roivant Sciences Ltd. | 1.29% | 220,126 | $7.8M | Add +71.8% |
| DMRA Damora Therapeutics Inc. | 1.22% | 284,430 | $7.4M | Add +180.9% |
| AXSM Axsome Therapeutics Inc. | 1.16% | 28,826 | $7.1M | Add +105.1% |
| DFTX Definium Therapeutics Inc. | 1.15% | 148,647 | $7.0M | Add +48.8% |
| DNTH Dianthus Therapeutics Inc. | 1.04% | 64,723 | $6.3M | Add +19.3% |
| COGT Cogent Biosciences Inc. | 0.94% | 147,510 | $5.7M | Reduce -1.3% |
| ERAS Erasca Inc. | 0.93% | 308,007 | $5.6M | Add +38.5% |
| PTGX Protagonist Therapeutics Inc. | 0.92% | 45,400 | $5.6M | Add +1035.0% |
| NERV Minerva Neurosciences Inc. | 0.92% | 1,001,373 | $5.6M | Add +303.0% |
| EDIT Editas Medicine Inc. | 0.71% | 1,330,500 | $4.3M | New |
| CTMX Cytomx Therapeutics Inc. | 0.67% | 1,085,398 | $4.1M | Add +192.3% |
| EPRX Eupraxia Pharmaceuticals Inc. | 0.67% | 610,785 | $4.0M | Add +40.9% |
| STRO Sutro Biopharma Inc. | 0.63% | 159,118 | $3.8M | New |
| RLAY Relay Therapeutics Inc. | 0.55% | 178,222 | $3.3M | Reduce -30.9% |
| CLDX Celldex Therapeutics Inc. | 0.53% | 86,664 | $3.2M | Add +195.8% |
| ASND Ascendis Pharma A/S | 0.52% | 11,869 | $3.2M | Reduce -2.5% |
| SGMT Sagimet Biosciences Inc. Class A | 0.51% | 403,545 | $3.1M | New |
| ZLAB Zai Lab Ltd.-ADR | 0.48% | 136,016 | $2.9M | Add +74.7% |
| SABS Sab Biotherapeutics Inc. | 0.47% | 736,077 | $2.9M | Add +636.1% |
| MDGL Madrigal Pharmaceuticals Inc. | 0.44% | 4,973 | $2.7M | Add +46.6% |
| PRAX Praxis Precision Medicines I | 0.42% | 7,540 | $2.5M | New |
| RLMD Relmada Therapeutics Inc. | 0.40% | 348,265 | $2.4M | New |
| AGIO Agios Pharmaceuticals Inc. | 0.35% | 56,900 | $2.1M | Reduce -72.8% |
| XENE Xenon Pharmaceuticals Inc. | 0.34% | 33,300 | $2.1M | New |
| SVRA Savara Inc. | 0.31% | 309,103 | $1.9M | Add +4.5% |
| CCCC C4 Therapeutics Inc. | 0.29% | 381,169 | $1.8M | Add +567.8% |
| PCVX Vaxcyte Inc. | 0.29% | 29,800 | $1.8M | Reduce -72.5% |
| CELC Celcuity Inc. | 0.28% | 16,252 | $1.7M | Add +170.9% |
| SNDX Syndax Pharmaceuticals Inc. | 0.27% | 77,930 | $1.6M | New |
| ZNTL Zentalis Pharmaceuticals Inc. | 0.24% | 317,600 | $1.5M | Add +188.7% |
| GPCR Structure Therapeutics Inc. | 0.24% | 26,800 | $1.4M | Add +197.8% |
| LONA Leonabio Inc. | 0.23% | 154,153 | $1.4M | Reduce -6.4% |
| IDYA Ideaya Biosciences Inc. | 0.23% | 37,865 | $1.4M | Reduce -56.1% |
| GERN Geron Corp. | 0.22% | 1,057,228 | $1.4M | Add +149.2% |
| ANL Adlai Nortye Group Ltd. | 0.21% | 113,207 | $1.3M | New |
| CRVS Corvus Pharmaceuticals Inc. | 0.20% | 82,890 | $1.2M | No change |
| ALKS Alkermes PLC | 0.20% | 23,285 | $1.2M | Reduce -3.7% |
| SYRE Spyre Therapeutics Inc. | 0.19% | 13,300 | $1.2M | Reduce -32.5% |
| CATX Perspective Therapeutics Inc. | 0.19% | 332,613 | $1.1M | Reduce -12.3% |
| OKUR Onkure Therapeutics Inc. Class A | 0.18% | 240,963 | $1.1M | New |
| SMMT Summit Therapeutics Inc. | 0.18% | 73,300 | $1.1M | New |
| ANTX AN2 Therapeutics Inc. | 0.17% | 208,946 | $1.0M | Add +4.6% |
| CTNM Contineum Therapeutics Inc. Class A | 0.16% | 60,541 | $992K | Add +123.8% |
| TRVI Trevi Therapeutics Inc. | 0.14% | 45,598 | $833K | Add +68.0% |
| VYGR Voyager Therapeutics Inc. | 0.13% | 230,406 | $772K | Add +100.0% |
| IVA Inventiva SA - ADR | 0.12% | 200,141 | $757K | No change |
| ENGN Engene Therapeutics Inc. | 0.12% | 411,065 | $711K | New |
| LRMR Larimar Therapeutics Inc. | 0.12% | 230,921 | $704K | Reduce -10.0% |
| IKT Inhibikase Therapeutics Inc. | 0.12% | 346,900 | $704K | Add +6.5% |
| NGNE Neurogene Inc. | 0.11% | 22,060 | $694K | New |
| IHI iShares U.S. Medical Devices | 0.11% | 13,800 | $682K | New |
| SLN Silence Therapeutics PLC-ADR | 0.11% | 60,107 | $660K | Reduce -61.7% |
| KRYS Krystal Biotech Inc. | 0.11% | 1,774 | $659K | Reduce -58.9% |
| IRD Opus Genetics Inc. | 0.10% | 143,137 | $588K | Add +6.6% |
| PALI Palisade Bio Inc. | 0.09% | 272,204 | $569K | Add +27.7% |
| EOLS Evolus Inc. | 0.09% | 78,057 | $542K | No change |
| UNCY Unicycive Therapeutics Inc. | 0.09% | 103,400 | $521K | Add +85.6% |
| CMPX Compass Therapeutics Inc. | 0.08% | 233,066 | $510K | Reduce -54.9% |
| BCRX Biocryst Pharmaceuticals Inc. | 0.08% | 51,024 | $510K | Reduce -50.2% |
| DRUG Bright Minds Biosciences Inc. | 0.07% | 6,395 | $449K | No change |
| PRTA Prothena Corp. PLC | 0.07% | 43,300 | $424K | No change |
| GLUE Monte Rosa Therapeutics Inc. | 0.07% | 16,800 | $407K | Reduce -25.4% |
| OLMA Olema Pharmaceuticals Inc. | 0.07% | 31,476 | $394K | New |
| MIST Milestone Pharmaceuticals Inc. | 0.06% | 270,233 | $362K | Reduce -18.9% |
| ENTX Entera Bio Ltd. | 0.06% | 191,354 | $339K | Reduce -6.9% |
| CUE Cue Biopharma Inc. | 0.06% | 10,702 | $338K | New |
| MBX MBX Biosciences Inc. | 0.05% | 6,000 | $331K | New |
| BEAM Beam Therapeutics Inc. | 0.05% | 8,804 | $302K | No change |
| AZN Astrazeneca PLC | 0.04% | 1,400 | $265K | New |
| AMLX Amylyx Pharmaceuticals Inc. | 0.04% | 14,540 | $261K | Reduce -12.8% |
| STOK Stoke Therapeutics Inc. | 0.04% | 7,745 | $255K | New |
| VKTX Viking Therapeutics Inc. | 0.04% | 7,404 | $252K | New |
| LPCN Lipocine Inc. | 0.03% | 78,842 | $202K | Reduce -36.9% |
| CRBP Corbus Pharmaceuticals Holdi | 0.03% | 21,432 | $201K | Reduce -75.0% |
| PMN Promis Neurosciences Inc. | 0.02% | 10,600 | $139K | No change |
| WVE Wave Life Sciences Ltd. | 0.02% | 19,048 | $100K | New |
| PMVP PMV Pharmaceuticals Inc. | 0.01% | 53,569 | $72K | Reduce -15.6% |
| FULC Fulcrum Therapeutics Inc. | 0.01% | 18,089 | $66K | Reduce -52.5% |
| QURE Uniqure NV | 0.00% | 338 | $15K | New |
Portfolio Sells Q1 2026 → Q2 2026
| CG ONCOLOGY INC | Sold out | 0.00% | −30.61 |
| TYRA Tyra Biosciences Inc. | Sold out | 0.00% | −2.35 |
| TANGO THERAPEUTICS INC | Sold out | 0.00% | −1.98 |
| AGIO Agios Pharmaceuticals Inc. | Reduce -72.8% | 0.35% | −1.88 |
| AVALO THERAPEUTICS INC | Sold out | 0.00% | −1.69 |
| PCVX Vaxcyte Inc. | Reduce -72.5% | 0.29% | −1.69 |
| MINERVA NEUROSCIENCES INC | Sold out | 0.00% | −1.68 |
| PHARVARIS N V | Sold out | 0.00% | −1.28 |
| SLNO Soleno Therapeutics Inc. | Sold out | 0.00% | −1.22 |
| ENLIVEN THERAPEUTICS INC | Sold out | 0.00% | −1.17 |
| CYTOMX THERAPEUTICS INC. | Sold out | 0.00% | −1.05 |
| CENTURY THERAPEUTICS INC | Sold out | 0.00% | −0.99 |
| COGT Cogent Biosciences Inc. | Reduce -1.3% | 0.94% | −0.86 |
| KALV Kalvista Pharmaceuticals Inc. | Sold out | 0.00% | −0.81 |
| CMPX Compass Therapeutics Inc. | Reduce -54.9% | 0.08% | −0.78 |
| COMPASS THERAPEUTICS INC | Sold out | 0.00% | −0.70 |
| DIANTHUS THERAPEUTICS INC | Sold out | 0.00% | −0.70 |
| IDYA Ideaya Biosciences Inc. | Reduce -56.1% | 0.23% | −0.67 |
| EUPRAXIA PHARMACEUTICALS INC | Sold out | 0.00% | −0.63 |
| MLYS Mineralys Therapeutics Inc. | Sold out | 0.00% | −0.59 |
| SOLENO THERAPEUTICS INC | Sold out | 0.00% | −0.57 |
| SAB BIOTHERAPEUTICS INC | Sold out | 0.00% | −0.48 |
| VAXCYTE INC | Sold out | 0.00% | −0.37 |
| ASND Ascendis Pharma A/S | Reduce -2.5% | 0.52% | −0.35 |
| CATX Perspective Therapeutics Inc. | Reduce -12.3% | 0.19% | −0.31 |
| LONA Leonabio Inc. | Reduce -6.4% | 0.23% | −0.30 |
| REPL Replimune Group Inc. | Sold out | 0.00% | −0.29 |
| MAZE Maze Therapeutics Inc. | Sold out | 0.00% | −0.29 |
| CLYM Climb Bio Inc. | Sold out | 0.00% | −0.28 |
| LPCN Lipocine Inc. | Reduce -36.9% | 0.03% | −0.28 |
| CMPS Compass Pathways PLC | Sold out | 0.00% | −0.27 |
| RLAY Relay Therapeutics Inc. | Reduce -30.9% | 0.55% | −0.26 |
| LRMR Larimar Therapeutics Inc. | Reduce -10.0% | 0.12% | −0.25 |
| KRYS Krystal Biotech Inc. | Reduce -58.9% | 0.11% | −0.24 |
| BCRX Biocryst Pharmaceuticals Inc. | Reduce -50.2% | 0.08% | −0.22 |
| CRBP Corbus Pharmaceuticals Holdi | Reduce -75.0% | 0.03% | −0.22 |
| DNLI Denali Therapeutics Inc. | Sold out | 0.00% | −0.21 |
| UTHR United Therapeutics Corp. | Sold out | 0.00% | −0.21 |
| LLY Eli Lilly & Co. | Sold out | 0.00% | −0.21 |
| VSTM Verastem Inc. | Sold out | 0.00% | −0.21 |
| LIQUIDIA CORPORATION | Sold out | 0.00% | −0.20 |
| CNTX Context Therapeutics Inc. | Sold out | 0.00% | −0.16 |
| SLN Silence Therapeutics PLC-ADR | Reduce -61.7% | 0.11% | −0.15 |
| NTLA Intellia Therapeutics Inc. | Sold out | 0.00% | −0.13 |
| SYRE Spyre Therapeutics Inc. | Reduce -32.5% | 0.19% | −0.12 |
| EWTX Edgewise Therapeutics Inc. | Sold out | 0.00% | −0.12 |
| NKTR Nektar Therapeutics | Sold out | 0.00% | −0.10 |
| SEPN Septerna Inc. | Sold out | 0.00% | −0.09 |
| OCUL Ocular Therapeutix Inc. | Sold out | 0.00% | −0.08 |
| FULC Fulcrum Therapeutics Inc. | Reduce -52.5% | 0.01% | −0.08 |
Portfolio Buys Q1 2026 → Q2 2026
| CGON CG Oncology Inc. | Add +2389.8% | 22.12% | +20.51 |
| TNGX Tango Therapeutics Inc. | Add +543.0% | 15.79% | +12.49 |
| RVMD Revolution Medicines Inc. | Add +199.6% | 7.48% | +5.01 |
| PHVS Pharvaris NV | Add +348.4% | 4.42% | +2.89 |
| MIRM Mirum Pharmaceuticals Inc. | New | 2.13% | +2.13 |
| MANE Veradermics Inc. | New | 1.62% | +1.62 |
| ASMB Assembly Biosciences Inc. | Add +671.5% | 1.96% | +1.47 |
| AVTX Avalo Therapeutics Inc. | Add +260.5% | 2.35% | +1.35 |
| LQDA Liquidia Corp. | Add +36.6% | 3.38% | +1.15 |
| AVBP Arrivent Biopharma Inc. | Add +390.7% | 1.41% | +1.05 |
| ELVN Enliven Therapeutics Inc. | Add +122.8% | 3.06% | +1.04 |
| XNCR Xencor Inc. | Add +360.4% | 1.29% | +0.99 |
| ABVX Abivax SA-ADR | Add +158.6% | 2.45% | +0.94 |
| TARS Tarsus Pharmaceuticals Inc. | Add +491.3% | 1.31% | +0.87 |
| PTGX Protagonist Therapeutics Inc. | Add +1035.0% | 0.92% | +0.79 |
| TSHA Taysha Gene Therapies Inc. | Add +140.4% | 1.64% | +0.76 |
| EDIT Editas Medicine Inc. | New | 0.71% | +0.71 |
| STRO Sutro Biopharma Inc. | New | 0.63% | +0.63 |
| DFTX Definium Therapeutics Inc. | Add +48.8% | 1.15% | +0.56 |
| SGMT Sagimet Biosciences Inc. Class A | New | 0.51% | +0.51 |
| NERV Minerva Neurosciences Inc. | Add +303.0% | 0.92% | +0.45 |
| AXSM Axsome Therapeutics Inc. | Add +105.1% | 1.16% | +0.42 |
| PRAX Praxis Precision Medicines I | New | 0.42% | +0.42 |
| RLMD Relmada Therapeutics Inc. | New | 0.40% | +0.40 |
| DMRA Damora Therapeutics Inc. | Add +180.9% | 1.22% | +0.40 |
| CYTK Cytokinetics Inc. | Add +93.0% | 1.66% | +0.39 |
| SABS Sab Biotherapeutics Inc. | Add +636.1% | 0.47% | +0.35 |
| XENE Xenon Pharmaceuticals Inc. | New | 0.34% | +0.34 |
| SNDX Syndax Pharmaceuticals Inc. | New | 0.27% | +0.27 |
| CCCC C4 Therapeutics Inc. | Add +567.8% | 0.29% | +0.25 |
| CLDX Celldex Therapeutics Inc. | Add +195.8% | 0.53% | +0.24 |
| ANL Adlai Nortye Group Ltd. | New | 0.21% | +0.21 |
| OKUR Onkure Therapeutics Inc. Class A | New | 0.18% | +0.18 |
| SMMT Summit Therapeutics Inc. | New | 0.18% | +0.18 |
| ROIV Roivant Sciences Ltd. | Add +71.8% | 1.29% | +0.17 |
| ZNTL Zentalis Pharmaceuticals Inc. | Add +188.7% | 0.24% | +0.16 |
| CTMX Cytomx Therapeutics Inc. | Add +192.3% | 0.67% | +0.12 |
| ENGN Engene Therapeutics Inc. | New | 0.12% | +0.12 |
| NGNE Neurogene Inc. | New | 0.11% | +0.11 |
| IHI iShares U.S. Medical Devices | New | 0.11% | +0.11 |
| GPCR Structure Therapeutics Inc. | Add +197.8% | 0.24% | +0.10 |
| CELC Celcuity Inc. | Add +170.9% | 0.28% | +0.07 |
| OLMA Olema Pharmaceuticals Inc. | New | 0.07% | +0.07 |
| CUE Cue Biopharma Inc. | New | 0.06% | +0.06 |
| MBX MBX Biosciences Inc. | New | 0.05% | +0.05 |
| CTNM Contineum Therapeutics Inc. Class A | Add +123.8% | 0.16% | +0.05 |
| AZN Astrazeneca PLC | New | 0.04% | +0.04 |
| STOK Stoke Therapeutics Inc. | New | 0.04% | +0.04 |
| VKTX Viking Therapeutics Inc. | New | 0.04% | +0.04 |
| TRVI Trevi Therapeutics Inc. | Add +68.0% | 0.14% | +0.04 |